These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 37805158)
1. The association of serum neurofilament light chains with early symptoms related to Parkinson's disease: A cross-sectional study. Wang X; Yang X; He W; Song X; Zhang G; Niu P; Chen T J Affect Disord; 2023 Dec; 343():144-152. PubMed ID: 37805158 [TBL] [Abstract][Full Text] [Related]
2. Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson's disease. Mao S; Teng X; Li Z; Zu J; Zhang T; Xu C; Cui G Brain Res; 2023 Apr; 1805():148271. PubMed ID: 36754139 [TBL] [Abstract][Full Text] [Related]
3. Association between serum neurofilament light chain levels and sleep disorders in patients with Parkinson's disease. Li Y; Li F; Liu X; Zu J; Zhang W; Zhou S; Zhu J; Zhang T; Cui G; Xu C Neurosci Lett; 2023 Aug; 812():137394. PubMed ID: 37437874 [TBL] [Abstract][Full Text] [Related]
4. Associations of sleep disorders with serum neurofilament light chain levels in Parkinson's disease. Qi WY; Sun Y; Guo Y; Tan L BMC Neurol; 2024 May; 24(1):147. PubMed ID: 38693483 [TBL] [Abstract][Full Text] [Related]
6. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease. Ng ASL; Tan YJ; Yong ACW; Saffari SE; Lu Z; Ng EY; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Keong NCH; Tay KY; Au WL; Tan LCS; Tan EK Mol Neurodegener; 2020 Jun; 15(1):33. PubMed ID: 32503574 [TBL] [Abstract][Full Text] [Related]
7. Correlations among serum alpha-(1,6)-fucosyltransferase and early symptoms associated with Parkinson's disease: A cross-sectional retrospective study. Wang QR; Yu X; Li Y; Zhu MZ Brain Res Bull; 2024 Jun; 212():110959. PubMed ID: 38643887 [TBL] [Abstract][Full Text] [Related]
8. Serum Neurofilament Dynamics Predicts Cognitive Progression in de novo Parkinson's Disease. Ma LZ; Zhang C; Wang H; Ma YH; Shen XN; Wang J; Tan L; Dong Q; Yu JT J Parkinsons Dis; 2021; 11(3):1117-1127. PubMed ID: 33935105 [TBL] [Abstract][Full Text] [Related]
9. The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease. Teng X; Mao S; Wu H; Shao Q; Zu J; Zhang W; Zhou S; Zhang T; Zhu J; Cui G; Xu C J Neurochem; 2023 Apr; 165(2):268-276. PubMed ID: 36776136 [TBL] [Abstract][Full Text] [Related]
11. Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease. Aamodt WW; Waligorska T; Shen J; Tropea TF; Siderowf A; Weintraub D; Grossman M; Irwin D; Wolk DA; Xie SX; Trojanowski JQ; Shaw LM; Chen-Plotkin AS Mov Disord; 2021 Dec; 36(12):2945-2950. PubMed ID: 34480363 [TBL] [Abstract][Full Text] [Related]
12. Relationship between increased serum neurofilament light chain and glial fibrillary acidic protein levels with non-motor symptoms in patients with Parkinson's disease. Yin P; Niu X; Guan C; Zhang Z; Liu Y; Li J; Cui G; Zan K; Xu C Psychogeriatrics; 2024 Mar; 24(2):415-425. PubMed ID: 38339819 [TBL] [Abstract][Full Text] [Related]
13. Blood neurofilament light chain in Parkinson's disease. Buhmann C; Magnus T; Choe CU J Neural Transm (Vienna); 2023 Jun; 130(6):755-762. PubMed ID: 37067597 [TBL] [Abstract][Full Text] [Related]
14. Plasma neurofilament light chain levels are associated with depressive and anxiety symptoms in Parkinson's disease. Yin W; Zhu Y; Yang B; Wang F; Yin K; Zhou C; Ren H; Yang X Neurol Sci; 2022 Apr; 43(4):2839-2843. PubMed ID: 35088243 [TBL] [Abstract][Full Text] [Related]
15. Serum NFL discriminates Parkinson disease from essential tremor and reflect motor and cognition severity. Huang Y; Huang C; Zhang Q; Shen T; Sun J BMC Neurol; 2022 Jan; 22(1):39. PubMed ID: 35086487 [TBL] [Abstract][Full Text] [Related]
16. Serum neurofilament light chain in LRRK2 related Parkinson's disease: A five years follow-up. Nabizadeh F; Mohamadzadeh O; Hosseini H; Rasouli K; Afyouni NE J Clin Neurosci; 2023 Apr; 110():12-18. PubMed ID: 36780781 [TBL] [Abstract][Full Text] [Related]
17. Association of Neurofilament Light With the Development and Severity of Parkinson Disease. Halloway S; Desai P; Beck T; Aggarwal N; Agarwal P; Evans D; Rajan KB; Neurology; 2022 May; 98(22):e2185-e2193. PubMed ID: 35418452 [TBL] [Abstract][Full Text] [Related]
18. Serum neurofilament is associated with motor function, cognitive decline and subclinical cardiac damage in advanced Parkinson's disease (MARK-PD). Niemann L; Lezius S; Maceski A; Leppert D; Englisch C; Schwedhelm E; Zeller T; Gerloff C; Kuhle J; Choe CU Parkinsonism Relat Disord; 2021 Sep; 90():44-48. PubMed ID: 34352610 [TBL] [Abstract][Full Text] [Related]
19. Plasma Neurofilament Light and p-tau181 and Risk of Psychosis in Parkinson's Disease. Gibson LL; Pollak TA; Heslegrave A; Hye A; Batzu L; Rota S; Trivedi D; Nicholson TR; Ffytche D; Zetterberg H; Chaudhuri KR; Aarsland D J Parkinsons Dis; 2022; 12(5):1527-1538. PubMed ID: 35466956 [TBL] [Abstract][Full Text] [Related]
20. Neurofilament light chain is associated with olfactory dysfunction in US adults: findings from National Health and Nutrition Examination Survey. Zhen J; Huang J; Cao Q; Cheung BMY; Li C Rhinology; 2024 Oct; 62(5):548-556. PubMed ID: 39075783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]